Deal Tracker · Therapeutic areas

Multi-therapy deals

34 Multi-therapy deals tracked by EPT across GCC, CIS & Central Asia, MENA & Africa — localization, distribution & M&A. Most active: Abdi İbrahim, Kazakhstan Ministry of Health, Laprophan & Mubadala Bio. Latest: Galenicum → Al Ittihad Drug Store (Distribution, 31 Oct 2026).

• Galenicum → Al Ittihad Drug Store
  Distribution · GCC · Undisclosed · 31 Oct 2026
• Novartis → Department of Health – Abu Dhabi
  Partnership / Collaboration · GCC · Undisclosed · 28 Oct 2026
• Casablanca Stock Exchange IPO → Laprophan
  Equity / Investment · MENA · $225m · 28 Oct 2026
• Roche → Iraq Ministry of Health
  Partnership / Collaboration · MENA · Undisclosed · 26 Oct 2026
• HarmeeCare Pharmaceuticals → Kilitch Estro Biotech
  M&A / Acquisition · Africa · $14m · 23 Oct 2026
• Mubadala Bio → Arabian Ethicals
  Distribution · GCC · 22 Oct 2026
• Laprophan → Polymedic
  M&A / Acquisition · Africa · 21 Oct 2026
• Sanofi → Mubadala Bio
  Distribution · GCC · 20 Oct 2026
• Yangtze River Pharmaceutical → Pharma Invest
  Technology transfer / Localization · Africa · 15 Oct 2026
• Sandoz → Tabuk Pharmaceuticals
  Technology transfer / Localization · GCC · Undisclosed · 13 Oct 2026
• Sana Pharma → National Pharmaceutical Industries
  Partnership / Collaboration · GCC · 8 Oct 2026
• Gen İlaç → Azerbaijan Business Development Fund
  Joint venture · CIS & Central Asia · $67m · 5 Oct 2026
• Undisclosed Chinese manufacturer → Newbury Pharmaceuticals
  Licensing · MENA · Undisclosed · 28 Sept 2026
• Chiesi → Abdi İbrahim
  Distribution · Türkiye · Undisclosed · 16 Sept 2026
• Alfasigma → Nordic Pharma
  M&A / Acquisition · Global ex-US · See terms · 9 Aug 2026
• Gypto Pharma → Bacha
  Distribution · Africa · Undisclosed · 4 Aug 2026
• Sino Biopharmaceutical → Tempo Scan
  Joint venture · Southeast Asia · Undisclosed · 24 Jul 2026
• Menarini → ADCAN Pharma
  Technology transfer / Localization · GCC · Undisclosed · 12 Jun 2026
• LVP Pharma → Rameda
  Equity / Investment · MENA · EGP 847m for 8.3% · 10 Jun 2026
• Kazakhstan Ministry of Health → Steppe Pharmaceuticals
  Technology transfer / Localization · CIS & Central Asia · $71m · 26 May 2026
• Hanmi Pharmaceutical → Organon
  Distribution · Southeast Asia · $34m · 21 May 2026
• Kazakhstan Ministry of Health → Karaganda Pharmaceutical Complex
  Technology transfer / Localization · CIS & Central Asia · $89.7m · 15 May 2026
• AbbVie & Abbott → Groupe Saidal
  Partnership / Collaboration · MENA · Undisclosed · 13 May 2026
• Livzon → Imexpharm
  M&A / Acquisition · Southeast Asia · $221m · 11 May 2026
• Lotus Pharmaceutical → Sandoz Philippines
  M&A / Acquisition · Southeast Asia · Undisclosed · 3 Apr 2026
• EBRD → Samarkand England Eco-Medical & Bayan Medical
  Equity / Investment · CIS & Central Asia · Up to €20 million · 26 Feb 2026
• Chemo & Olpha → CCL Pharmaceuticals
  Supply / Manufacturing · GCC · Undisclosed · 28 Jan 2026
• Abdi İbrahim → Abdi Ibrahim Global Pharm
  Technology transfer / Localization · CIS & Central Asia · $83m · 22 Jan 2026
• World Medicine & Rompharm → MSP-ROMPHARM
  Technology transfer / Localization · CIS & Central Asia · $78m · 22 Jan 2026
• Nobel İlaç → Nobel Almaty Pharmaceutical Factory
  Technology transfer / Localization · CIS & Central Asia · $84m · 22 Jan 2026
• Sinopharm, Sinovac & Kangtai Biological Technology → AltINFARM
  Technology transfer / Localization · CIS & Central Asia · $125m · 22 Jan 2026
• Celltrion → Hikma Pharmaceuticals
  Licensing · MENA · 6 Oct 2025
• Afreximbank → Med Aditus Pharmaceutical Kenya
  Equity / Investment · Africa · $40m · 29 Nov 2024
• Kelix Bio → Khalifa University of Science & Technology + Mubadala Investment
  Partnership / Collaboration · GCC · Undisclosed · 30 Apr 2024